News
In a landmark shift, the US Food and Drug Administration (FDA) has announced a transformative initiative to advance public ...
I hope this video shines a light on the immense pain that experimenters inflict on tens of millions of animals every year,” the veteran filmmaker says in a statement.
The FDA will begin replacing animal testing in the development of monoclonal antibody therapies and other drugs with ...
On Thursday, shares in Charles River Laboratories, a leading contract research organizations that has stirred controversy ...
Recursion Pharmaceuticals' stock is soaring today on news the FDA is planning on phasing out some animal testing, replacing ...
The FDA is moving away from requiring animal models for investigational new drug (IND) applications for new monoclonal ...
The FDA announced a shift away from animal testing for drug approval, citing advanced alternatives like AI and organoids ...
The Trump administration’s deep cuts to federal health agencies and research grants have put at risk lab animals from mice to ...
Shares of Charles River Labs (CRL) crashed 28% after the U.S. FDA (Food and Drug Administration) announced plans to phase out the need for ...
The US Food and Drug Administration announced Thursday that it will be phasing out a requirement that monoclonal antibodies ...
The U.S. Food and Drug Administration is replacing animal testing with human-relevant methods, including artificial ...
The FDA is phasing out an animal testing requirement for monoclonal antibody therapies in favor of testing drugs on “lab-grown human ‘organoids.'" ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results